ClassID:

108779

C12N5/0648 - CPC Classification

Classification description:

Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system Splenocytes

Recent Application in this class:
#1
20260002127
2026-01-01

METHOD FOR PRODUCING IMMORTALIZED CELL

#2
20250387461
2025-12-25

COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE

#3
20240148845
2024-05-09

GENETICALLY MODIFIED ANTI-THIRD PARTY CENTRAL MEMORY T CELLS AND USE OF SAME IN IMMUNOTHERAPY

#4
20220273778
2022-09-01

METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE

#5
20220080034
2022-03-17

Genetically modified anti-third party central memory T cells and use of same in immunotherapy

#6
20220010269
2022-01-13

Engineering Of Innervated Tissue And Modulation Of Peripheral Organ Activity

#7
20210128612
2021-05-06

Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells

#8
20200147133
2020-05-14

Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System

#9
20200046816
2020-02-13

Compositions and Methods for Antigen-Specific Tolerance

#10
20180353577
2018-12-13

Cell therapy for the treatment of neurodegeneration

#11
20180214483
2018-08-02

Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells

#12
20180207272
2018-07-26

Genetically modified anti-third party central memory T cells and use of same in immunotherapy

#13
20180207247
2018-07-26

Methods of transplantation and disease treatment

#14
20180163173
2018-06-14

SELECTIVE SURFACES FOR, AND METHODS OF, SELECTING A POPULATION OF STEM AND PROGENITOR CELLS, AND USES THEREOF

#15
20180051254
2018-02-22

Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GVHD)

#16
20180030414
2018-02-01

Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GvHD)

#17
20170326211
2017-11-16

Cell therapy for the treatment of neurodegeneration

#18
20170274069
2017-09-28

METHOD FOR THE CANCER TREATMENT AND PREVENTION OF METASTATIC DISEASE

#19
20160287661
2016-10-06

METHOD FOR TREATING CANCER BY ADMINISTERING ATP AND POLYMYXIN B

#20
20160206655
2016-07-21

Acellular pro-inflammatory compositions, process for making same and methods of using same

#21
20150329824
2015-11-19

Z cells activated by zinc finger-like protein and uses thereof in cancer treatment

#22
20140219969
2014-08-07

Cell therapy for the treatment of neurodegeneration

#23
20130330334
2013-12-12

Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GvHD)

#24
20120263692
2012-10-18

Engineered Xenogeneic Cells for Repair of Biological Tissue

#25
20120004642
2012-01-05

IN VITRO MICRO-ORGANS, AND USES RELATED THERETO

#26
20120003195
2012-01-05

IN VITRO MICRO-ORGANS, AND USES RELATED THERETO

#27
20120003194
2012-01-05

IN VITRO MICRO-ORGANS, AND USES RELATED THERETO

#28
20100260781
2010-10-14

Treatment methods for autoimmune disorders

#29
20100068177
2010-03-18

Methods of organ regeneration using Hox11-expressing pluripotent cells

#30
20090068687
2009-03-12

Screening platform for discovery of immunomodulatory activities in traditional medicine

#31
20080102054
2008-05-01

Compositions Containing Agm Cells And Methods Of Use Thereof

#32
20070116688
2007-05-24

Hox11+, CD45− cells and methods of organ regeneration using the same

#33
20050191743
2005-09-01

Three-dimensional peripheral lymphoid organ cell cultures

#34
20050158288
2005-07-21

Methods of organ regeneration using -expressing pluripotent cells

#35
20050153367
2005-07-14

Method of detecting immune response